GlassScriptPhysician profile
Neeraj Manchanda
NPI 1790711976
$22,557.76
in general payments reported to CMS, 2019-2025
70 companies · $3,573 in 2025
The $3,573 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,826 · 2020: $2,435 · 2021: $3,708 · 2022: $3,358 · 2023: $3,253 · 2024: $3,406 · 2025: $3,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,082.86 |
| Education | $148.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,778.70 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Sk Life Science, INC. | $1,006.65 | 2022-2025 | |
| Harmony Biosciences LLC | $1,004.00 | 2020-2025 | Wakix |
| Novartis Pharmaceuticals Corporation | $992.74 | 2019-2025 | |
| Eisai INC. | $982.42 | 2021-2025 | |
| Ucb, INC. | $967.99 | 2019-2024 | Briviact, Nayzilam |
| Amgen INC. | $965.71 | 2019-2022 | |
| Abbvie INC. | $961.78 | 2021-2025 | |
| Lilly USA, LLC | $933.63 | 2020-2025 | Amyvid, Kisunla, Emgality |
| Biogen, INC. | $878.07 | 2020-2025 | Leqembi, Vumerity, Tysabri |
| Pfizer INC. | $736.39 | 2021-2025 | |
| Lundbeck LLC | $726.10 | 2019-2025 | Vyepti, Rexulti |
| Jazz Pharmaceuticals INC. | $693.92 | 2019-2025 | Rylaze |
| Mdd US Operations, LLC | $639.71 | 2019-2024 | Gocovri, Gocovri |
| Acadia Pharmaceuticals INC | $602.77 | 2019-2025 | Nuplazid |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeraj Manchanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.